S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,509.43 +0.95%
Next Bullish Trade
Sign in
ELV

Elevance Health, Inc. ELV

$373.11 +0.26 (+0.07%)
Pullback · -1.86σ
Mkt cap $92.1B
P/E 16.7
Day $365.38 – $377.76
52wk $274.84 – $436.24
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Elevance Health, Inc. is a healthcare company listed in the US.

ELV last traded at $373.11, up 0.1% on the day; that's in the middle part of its 52-week range ($274.84–$436.24). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 38), the trend is strong (ADX 26), and volume is about normal (1.0×). On the business side, revenue is growing 1% year over year and the business keeps about 2 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
38
0–100 · <30 oversold
Trend strength · ADX
26
>25 = strong trend
Volume vs avg
1.03×
1× = average
Stretch from avg
-2.0 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
4–45
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+1.4%
year over year
Free-cash-flow margin
2.1%
cash kept per $ of sales
Debt / equity
0.69
lower = less leveraged
P/E ratio
16.7
price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $308.29 (fair range $308–$2751); today's price sits 23% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Intrinsic (DCF)
$308.29
Fair-value range
$308.29 – $2750.82
Margin of safety
-23%
Verdict
Overvalued
Accounting quality Adequate
  • ✓ More cash than debt
  • ✓ Positive retained earnings
  • ⚠ Receivables growing faster than revenue

Price implies ~5% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

ELV is a $92.1 billion company, priced at 17× last year's earnings.

Mkt cap $92.1B
P/E ttm 16.7
Fwd P/E
Beta
Day range $365.38 – $377.76
52w range $274.84 – $436.24
Avg vol
RSI(2) 6.0
ROE
Net mgn
FCF mgn 2.1%
Debt/Eq 0.69
Div yld
Sector Healthcare
Industry Healthcare Plans
Next earn
52-week range · today's price
$274.84$436.24

More on ELV